Samuel Backenroth's Net Worth
$177 Thousand
Who is Samuel Backenroth?
Samuel Backenroth does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Ohr Pharmaceutical Inc, and Vascular Biogenics Ltd..
SEC CIK
Samuel Backenroth's CIK is 0001579887
Past Insider Trading and Trends
2016 was Samuel Backenroth's most active year for acquiring shares with 20 total transactions. Samuel Backenroth's most active month to acquire stocks was the month of April. 2023 was Samuel Backenroth's most active year for disposing of shares, totalling 1 transactions. Samuel Backenroth's most active month to dispose stocks was the month of February. 2017 saw Samuel Backenroth paying a total of $50,000.30 for 471,430 shares, this is the most they've acquired in one year. In 2023 Samuel Backenroth cashed out on 525,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Ohr Pharmaceutical Inc (NBSE) No price found
CFO, Treasurer & SecretarySamuel Backenroth owns 212,596 units of Common Stock, par value $0.0001 per share and 11,630 units of Common Stock. In the year 2013 Samuel Backenroth acquired a total of 208,897 shares in Ohr Pharmaceutical Inc at a cost of $81,048.75.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 4
| +9.41% | 1K |
$6.00 | $6,000.00 | 11.63K |
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
Form 4
| +50.60% | 71.43K |
$0.70 | $50,000.30 | 212.6K |
Apr 10
| |||
Form 4
| +1.78% | 2.47K |
$2.84 | $6,997.44 | 141.17K |
Jun 20
| |||
Form 4
| +1.84% | 2.5K |
$3.17 | $7,926.01 | 138.7K |
May 23
| |||
Form 4
| +2,097.11% | 130K |
—
|
—
| 136.2K |
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
| +31.92% | 1.5K |
$6.75 | $10,125.00 | 6.2K |
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vascular Biogenics Ltd. (NTBL) Snapshot price: $0.4921
Chief Financial OfficerSamuel Backenroth owns 525,000 units of Ordinary Shares which is worth $258,352.50. In the year 2023 Samuel Backenroth filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 525K |
—
|
—
| 525K |
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||